In canine lymphoma, Ki‐67 has been demonstrated to predict grade [21, 22] and outcome in high‐grade B‐cell lymphoma treated with chemotherapy [23, 24]. This evidence concerns the gene MKI67 and B-cell non-Hodgkin lymphoma.